Indication
Lobular Carcinoma in Situ
2 clinical trials
2 products
2 drugs
Clinical trial
A Phase IIB Randomized Trial of Oral Tamoxifen vs. Topical 4-hydroxytamoxifen Gel vs. Control in Women With Atypical Hyperplasia or Lobular Carcinoma In SituStatus: Recruiting, Estimated PCD: 2026-12-31
Product
Topical 4-OHT gelDrug
VarlilumabDrug
TamoxifenClinical trial
Pure Florid and Pleomorphic Lobular Carcinoma in Situ of the Breast: Towards an Increasingly Uniform Management. A Multicenter Observational Retrospective Study.Status: Recruiting, Estimated PCD: 2024-04-30
Product
Adjuvant Hormone Therapy